8-K/AThe WireRoutine
Company Update
Filed Dec 4, 2018 · 7y ago · Accession 0001628280-18-014812
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Avalo Therapeutics, Inc.
- Ticker
- AVTX
- CIK
- 1534120
- Form type
- 8-K/A
- Filing date
- Dec 4, 2018
- Report date
- Sep 24, 2018
- Document
- docs-1065363xv1xcerc_xxfor.htm
- Size
- 880 KB